文献速递外周动脉疾病

下肢血运重建的慢性肢体威胁性缺血患者生存预测模型

Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2019-05-28

基于美国血管质量倡议(VQI)2003年1月至2017年2月38470例因慢性肢体威胁性缺血(CLTI)行腹股沟下旁路或腔内治疗的患者,构建仅含术前变量的Cox生存模型,分别预测30天、2年和5年生存。模型区分度良好(C指数0.76、0.72、0.71),可将患者分为低、中、高危三组,辅助循证血运重建决策。

要点

  • 模型仅用术前变量预测30天、2年和5年生存,C指数分别为0.76、0.72、0.71。
  • 低危患者占84%,中危10%,高危6.5%;低危组腔内治疗比例较低(59% vs 75%)。
  • 年龄>80岁、氧依赖COPD、5期CKD和卧床状态是死亡最强预测因子。

核心结论

  • 基于大样本CLTI血运重建队列的生存预测模型性能良好,可区分低、中、高危患者。
  • 多数适合保肢的CLTI患者围术期风险一般,预测可存活超过2年。
  • 模型有助于依据现行指南提供循证血运重建建议。

研究设计与样本

  • 回顾性队列研究,数据来自美国血管质量倡议(VQI),纳入2003年1月至2017年2月因CLTI行腹股沟下旁路或腔内治疗的患者。
  • 共纳入38470例独特CLTI患者,其中63%(n=24214)接受腔内治疗,37%(n=14256)接受腹股沟下旁路。
  • 使用仅术前变量构建Cox生存模型,分别建模30天、2年和5年生存。
  • 风险分组定义:低危为30天生存>97%且2年生存>70%;中危为30天生存95%-97%或2年生存50%-70%;高危为30天生存<95%或2年生存<50%。

主要发现

  • Kaplan-Meier估计的30天、2年和5年总生存率分别为98%、81%和69%。
  • 低、中、高危组分别占84%、10%和6.5%。
  • 低危组接受腔内治疗的比例显著低于高危组(低危59% vs 高危75%,P < .0001)。
  • 三个模型中独立死亡预测因素相似,效应最大者为年龄>80岁、氧依赖COPD、5期CKD和卧床状态。
  • 30天、2年和5年模型的C指数分别为0.76、0.72和0.71;手术类型(开放或腔内)在所有模型中均不显著,且不影响C指数。

关键数值与推荐

  • 低危:30天生存>97%且2年生存>70%。
  • 中危:30天生存95%-97%或2年生存50%-70%。
  • 高危:30天生存<95%或2年生存<50%。
  • 30天、2年和5年模型的C指数分别为0.76、0.72和0.71。

临床怎么用

  • 可利用术前变量将CLTI患者分为低、中、高危,辅助选择开放或腔内血运重建方式。
  • 对预测生存超过2年的患者,可参考BASIL试验结果考虑腹股沟下旁路的长期优势。
  • 模型尚需外部验证后方可用于常规临床决策。

局限性

  • 模型 derived 自美国VQI队列,需外部验证。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Accurate survival prediction critically influences decision-making in caring for patients with chronic limb-threatening ischemia (CLTI). The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial demonstrated that in patients who survived >2 years, there was a significant advantage to infrainguinal bypass compared with endovascular intervention, which increased with time. Validated survival models for patients with CLTI are lacking. METHODS: The Vascular Quality Initiative was interrogated for patients who underwent infrainguinal bypass or endovascular intervention for CLTI (January 2003-February 2017). Cox survival models were generated using only preoperative variables. Survival at 30 days, 2 years, and 5 years was modeled separately. Patients were defined as low risk (30-day survival >97% and 2-year survival >70%), medium risk (30-day survival 95%-97% or 2-year survival 50%-70%), and high-risk (30-day survival <95% or 2-year survival <50%). RESULTS: Among 38,470 unique CLTI patients, 63% (n = 24,214) underwent endovascular intervention and 37% (n = 14,256) underwent infrainguinal bypass. Kaplan-Meier estimates of overall survival at 30 days, 2 years, and 5 years were 98%, 81%, and 69%, respectively. The proportion of patients in the low-, medium-, and high-risk groups was 84%, 10%, and 6.5%, respectively. Patients in the low-risk group were significantly less likely to undergo endovascular intervention compared with those in the high-risk group (low risk, 59% endovascular; high risk, 75% endovascular; P < .0001). Independent predictors of death were similar in all three models, with greatest magnitude of effect associated with age >80 years, oxygen-dependent chronic obstructive pulmonary disease, stage 5 chronic kidney disease, and bedbound status. The C index for the 30-day model, 2-year model, and 5-year model was 0.76, 0.72, and 0.71, respectively. Procedure type (open or endovascular) was not significant in any models and did not have an impact on C indices. CONCLUSIONS: These survival prediction models, derived from a large U.S. cohort of patients who underwent revascularization for CLTI, demonstrated good performance and should be validated. Most CLTI patients considered candidates for limb salvage were of average perioperative risk and were predicted to survive beyond 2 years. These models can differentiate patients into low-, medium-, and high-risk groups to facilitate evidence-based revascularization recommendations that are consistent with current treatment guidelines.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Simons JP, Schanzer A, Flahive JM, et al. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization. Eur J Vasc Endovasc Surg. 2019. PMID: 31151867. doi:10.1016/j.ejvs.2019.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。